drugset / Trial / NCT01471886
Comparison Of Ketorolac Tromethamine Versus Naproxen For Moderate to Severe Back Pain Treatment
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the non-inferiority of the clinical efficacy of two different drugs in the treatment of patients diagnosed with moderate to severe back pain.
Timeline
- Start
- 2013-03
- Primary completion
- 2013-10
- Completion
- 2013-11-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketorolac Tromethamine | Small molecule | 10 mg | Subcutaneous |
| Comparator | Naproxen | Small molecule | 250 mg | Oral |
Indications
No indication recorded.